Bridge Capture enables sensitive, scalable liquid biopsy in colorectal cancer pilot
Clinical study in Scientific Reports shows Bridge Capture™ detects key mutations from…
Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
A recognized pioneer in metabolomics, Metabolon is the most experienced and trusted…
B612 Foundation Announces Winner of Prestigious Schweickart Prize: Imperial College London’s Jordan Stone Leads Winning Proposal for International Panel on Asteroid Orbit Alteration, Recognized for its Foresight in Planetary Defense
SAN FRANCISCO, June 26, 2025 /PRNewswire/ --Â B612 Foundation today announced the recipient…
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
ROCKVILLE, Md. and SUZHOU, China, July 07, 2025 (GLOBE NEWSWIRE) -- Ascentage…
Immutheras Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions
Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions…
Countries Urged to Establish National Refrigeration Committees to Tackle Food, Health, Animals and Climate Challenges
PARIS, June 26, 2025 /PRNewswire/ -- On the occasion of World Refrigeration…
Esaote presents at ECVS 2025 the new generation of veterinary MRI, Vet -MR Grande ELITE
GENOA, Italy and ANTWERP, Belgium, July 3, 2025 /PRNewswire/ --Â Esaote, a leading…
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…
CCS Presents Four Peer-Reviewed Posters at American Diabetes Associations 85th Scientific Sessions
CCS’s latest evidence-based research reinforces the most innovative and intelligent approaches to…
Novo Nordisks subcutaneous and oral amycretin data published in The Lancet and presented at ADA 2025
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss…